-
1
-
-
0032583933
-
Hepatitis C
-
Di Bisceglie AM: Hepatitis C. Lancet 1998;351:351-355.
-
(1998)
Lancet
, vol.351
, pp. 351-355
-
-
Di Bisceglie, A.M.1
-
2
-
-
25844523297
-
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
-
Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin IT, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A: Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.
-
(2005)
Hepatology
, vol.42
, pp. 962-973
-
-
Simmonds, P.1
Bukh, J.2
Combet, C.3
Deleage, G.4
Enomoto, N.5
Feinstone, S.6
Halfon, P.7
Inchauspe, G.8
Kuiken, C.9
Maertens, G.10
Mizokami, M.11
Murphy, D.G.12
Okamoto, H.13
Pawlotsky, J.M.14
Penin, F.15
Sablon, E.16
Shin, I.T.17
Stuyver, L.J.18
Thiel, H.J.19
Viazov, S.20
Weiner, A.J.21
Widell, A.22
more..
-
3
-
-
0022444885
-
Interferon in viral hepatitis: Role in pathogenesis and treatment
-
Davis GL, Hoofnagle JH: Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986;6:1038-1041.
-
(1986)
Hepatology
, vol.6
, pp. 1038-1041
-
-
Davis, G.L.1
Hoofnagle, J.H.2
-
4
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
-
McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-1492.
-
(1998)
N Engl J Med
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.G.1
Gordon, S.C.2
Schiff, E.R.3
Shiffman, M.L.4
Lee, W.M.5
Rustgi, V.K.6
Goodman, Z.D.7
Ling, M.H.8
Cort, S.9
Albrecht, J.K.10
-
5
-
-
0032585237
-
2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
-
2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-1432.
-
(1998)
Lancet
, vol.352
, pp. 1426-1432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.S.3
Niederau, C.4
Minuk, G.S.5
Ideo, G.6
Bain, V.7
Heathcote, J.8
Zeuzem, S.9
Trepo, C.10
Albrecht, J.11
-
6
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales Jr, F.L.6
Haussinger, D.7
Diago, M.8
Carosi, G.9
Dhumeaux, D.10
Craxi, A.11
Lin, A.12
Hoffman, J.13
Yu, J.14
-
7
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
Rustgi, V.K.4
Shiffman, M.5
Reindollar, R.6
Goodman, Z.D.7
Koury, K.8
Ling, M.9
Albrecht, J.K.10
-
8
-
-
0036829986
-
Treatment of chronic hepatitis C: A systematic review
-
Chander G, Sulkowski MS, Jenckes MW, Torbenson MS, Herlong HF, Bass EB, Gebo KA: Treatment of chronic hepatitis C: a systematic review. Hepatology 2002;36:S135-S144.
-
(2002)
Hepatology
, vol.36
-
-
Chander, G.1
Sulkowski, M.S.2
Jenckes, M.W.3
Torbenson, M.S.4
Herlong, H.F.5
Bass, E.B.6
Gebo, K.A.7
-
9
-
-
4444232174
-
Predictors of response to therapy for chronic hepatitis C
-
Ferenci P: Predictors of response to therapy for chronic hepatitis C. Semin Liver Dis 2004;24:S25-S31.
-
(2004)
Semin Liver Dis
, vol.24
-
-
Ferenci, P.1
-
10
-
-
1442308277
-
Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: Who responds less well?
-
Zeuzem S: Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 2004;140:370-381.
-
(2004)
Ann Intern Med
, vol.140
, pp. 370-381
-
-
Zeuzem, S.1
-
11
-
-
15044353027
-
2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: Relationship of baseline viral levels and viral dynamics during and after therapy
-
2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy. Hepatol Res 2004;30:63-70.
-
(2004)
Hepatol Res
, vol.30
, pp. 63-70
-
-
Iino, S.1
Tomita, E.2
Kumada, H.3
Suzuki, H.4
Toyota, J.5
Kiyosawa, K.6
Tanikawa, K.7
Sata, M.8
Hayashi, N.9
Kakumu, S.10
Matsushima, T.11
Ohno, T.12
-
12
-
-
0041822106
-
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
-
Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J: Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 2003;38:645-652.
-
(2003)
Hepatology
, vol.38
, pp. 645-652
-
-
Davis, G.L.1
Wong, J.B.2
McHutchison, J.G.3
Manns, M.P.4
Harvey, J.5
Albrecht, J.6
-
13
-
-
28944436403
-
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load
-
Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H: Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load. J Med Virol 2006;78:83-90.
-
(2006)
J Med Virol
, vol.78
, pp. 83-90
-
-
Akuta, N.1
Suzuki, F.2
Sezaki, H.3
Suzuki, Y.4
Hosaka, T.5
Someya, T.6
Kobayashi, M.7
Saitoh, S.8
Watahiki, S.9
Sato, J.10
Kobayashi, M.11
Arase, Y.12
Ikeda, K.13
Kumada, H.14
-
14
-
-
22344457187
-
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
-
Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Matsuda M, Kobayashi M, Arase Y, Ikeda K, Kumada H: Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy. Intervirology 2005;48:372-380.
-
(2005)
Intervirology
, vol.48
, pp. 372-380
-
-
Akuta, N.1
Suzuki, F.2
Sezaki, H.3
Suzuki, Y.4
Hosaka, T.5
Someya, T.6
Kobayashi, M.7
Saitoh, S.8
Watahiki, S.9
Sato, J.10
Matsuda, M.11
Kobayashi, M.12
Arase, Y.13
Ikeda, K.14
Kumada, H.15
-
15
-
-
33846593397
-
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
-
Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H: Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. J Hepatol 2007;46:403-410.
-
(2007)
J Hepatol
, vol.46
, pp. 403-410
-
-
Akuta, N.1
Suzuki, F.2
Kawamura, Y.3
Yatsuji, H.4
Sezaki, H.5
Suzuki, Y.6
Hosaka, T.7
Kobayashi, M.8
Kobayashi, M.9
Arase, Y.10
Ikeda, K.11
Kumada, H.12
-
16
-
-
0025685188
-
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
-
Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990;87:9524-9528.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 9524-9528
-
-
Kato, N.1
Hijikata, M.2
Ootsuyama, Y.3
Nakagawa, M.4
Ohkoshi, S.5
Sugimura, T.6
Shimotohno, K.7
-
17
-
-
33847036713
-
A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b
-
Okamoto K, Akuta N, Kumada H, Kobayashi M, Matsuo Y, Tazawa H: A nucleotide sequence variation detection system for the core region of hepatitis C virus-1b. J Virol Methods 2007;141:1-6.
-
(2007)
J Virol Methods
, vol.141
, pp. 1-6
-
-
Okamoto, K.1
Akuta, N.2
Kumada, H.3
Kobayashi, M.4
Matsuo, Y.5
Tazawa, H.6
-
18
-
-
0036830567
-
Monitoring of viral levels during therapy of hepatitis C
-
Davis GL: Monitoring of viral levels during therapy of hepatitis C. Hepatology 2002;36:S145-S151.
-
(2002)
Hepatology
, vol.36
-
-
Davis, G.L.1
-
19
-
-
0032102892
-
Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy
-
Bekkering FC, Brouwer JT, Leroux-Roels G, Van Vlierberghe H, Elewaut A, Schalm SW: Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy. J Hepatol 1998;28:960-964.
-
(1998)
J Hepatol
, vol.28
, pp. 960-964
-
-
Bekkering, F.C.1
Brouwer, J.T.2
Leroux-Roels, G.3
Van Vlierberghe, H.4
Elewaut, A.5
Schalm, S.W.6
-
21
-
-
0032940812
-
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
-
Brouwer JT, Hansen BE, Niesters HG, Schalm SW: Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT. J Hepatol 1999;30:192-198.
-
(1999)
J Hepatol
, vol.30
, pp. 192-198
-
-
Brouwer, J.T.1
Hansen, B.E.2
Niesters, H.G.3
Schalm, S.W.4
-
22
-
-
0031924165
-
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
-
Zeuzem S, Lee JH, Franke A, Ruster B, Prummer O, Herrmann G, Roth WK: Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology 1998;27:1149-1156.
-
(1998)
Hepatology
, vol.27
, pp. 1149-1156
-
-
Zeuzem, S.1
Lee, J.H.2
Franke, A.3
Ruster, B.4
Prummer, O.5
Herrmann, G.6
Roth, W.K.7
-
23
-
-
0034102575
-
Natural history of hepatitis C and the impact of anti-viral therapy
-
Boyer N, Marcellin P: Natural history of hepatitis C and the impact of anti-viral therapy. Forum (Genova) 2000;10:4-18.
-
(2000)
Forum (Genova)
, vol.10
, pp. 4-18
-
-
Boyer, N.1
Marcellin, P.2
-
24
-
-
0035856208
-
Primary interferon resistance and treatment response in chronic hepatitis C infection: A pilot study
-
Jessner W, Gschwantler M, Steindl-Munda P, Hofer H, Watkins-Riedel T, Wrba F, Mueller C, Gangl A, Ferenci P: Primary interferon resistance and treatment response in chronic hepatitis C infection: A pilot study. Lancet 2001;358:1241-1242.
-
(2001)
Lancet
, vol.358
, pp. 1241-1242
-
-
Jessner, W.1
Gschwantler, M.2
Steindl-Munda, P.3
Hofer, H.4
Watkins-Riedel, T.5
Wrba, F.6
Mueller, C.7
Gangl, A.8
Ferenci, P.9
-
25
-
-
0036380991
-
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline
-
Layden JE, Layden TJ, Reddy KR, Levy-Drummer RS, Poulakos J, Neumann AU: First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline. J Viral Hepat 2002;9:340-345.
-
(2002)
J Viral Hepat
, vol.9
, pp. 340-345
-
-
Layden, J.E.1
Layden, T.J.2
Reddy, K.R.3
Levy-Drummer, R.S.4
Poulakos, J.5
Neumann, A.U.6
-
26
-
-
0032475822
-
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy
-
Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy. Science 1998;282:103-107.
-
(1998)
Science
, vol.282
, pp. 103-107
-
-
Neumann, A.U.1
Lam, N.P.2
Dahari, H.3
Gretch, D.R.4
Wiley, T.E.5
Layden, T.J.6
Perelson, A.S.7
-
27
-
-
0030039045
-
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
-
Zeuzem S, Schmidt JM, Lee JH, Ruster B, Roth WK: Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Hepatology 1996;23:366-371.
-
(1996)
Hepatology
, vol.23
, pp. 366-371
-
-
Zeuzem, S.1
Schmidt, J.M.2
Lee, J.H.3
Ruster, B.4
Roth, W.K.5
-
28
-
-
0036378151
-
First-phase parameters in hepatitis C viral kinetics
-
Zeuzem S, Herrmann E: First-phase parameters in hepatitis C viral kinetics. J Viral Hepat 2002;9:332-333.
-
(2002)
J Viral Hepat
, vol.9
, pp. 332-333
-
-
Zeuzem, S.1
Herrmann, E.2
-
29
-
-
9644254247
-
Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load
-
Tsubota A, Arase Y, Someya T, Suzuki Y, Suzuki F, Saitoh S, Ikeda K, Akuta N, Hosaka T, Kobayashi M, Kumada H: Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load. J Med Virol 2005;75:27-34.
-
(2005)
J Med Virol
, vol.75
, pp. 27-34
-
-
Tsubota, A.1
Arase, Y.2
Someya, T.3
Suzuki, Y.4
Suzuki, F.5
Saitoh, S.6
Ikeda, K.7
Akuta, N.8
Hosaka, T.9
Kobayashi, M.10
Kumada, H.11
-
30
-
-
33644804915
-
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
-
Iwasaki Y, Ikeda H, Araki Y, Osawa T, Kita K, Ando M, Shimoe T, Takaguchi K, Hashimoto N, Kobatake T, Tomita M, Kawaguchi M, Kobashi H, Sakaguchi K, Shiratori Y: Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 2006;43:54-63.
-
(2006)
Hepatology
, vol.43
, pp. 54-63
-
-
Iwasaki, Y.1
Ikeda, H.2
Araki, Y.3
Osawa, T.4
Kita, K.5
Ando, M.6
Shimoe, T.7
Takaguchi, K.8
Hashimoto, N.9
Kobatake, T.10
Tomita, M.11
Kawaguchi, M.12
Kobashi, H.13
Sakaguchi, K.14
Shiratori, Y.15
-
31
-
-
0345655291
-
Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression
-
Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J: Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003;125:1695-1704.
-
(2003)
Gastroenterology
, vol.125
, pp. 1695-1704
-
-
Hui, J.M.1
Sud, A.2
Farrell, G.C.3
Bandara, P.4
Byth, K.5
Kench, J.G.6
McCaughan, G.W.7
George, J.8
-
32
-
-
15744381704
-
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
-
Romero-Gomez M, Del Mar Viloria M, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, Corpas R, Cruz M, Grande L, Vazquez L, Munoz-De-Rueda P, Lopez-Serrano P, Gila A, Gutierrez ML, Perez C, Ruiz-Extremera A, Suarez E, Castillo J: Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005;128:636-641.
-
(2005)
Gastroenterology
, vol.128
, pp. 636-641
-
-
Romero-Gomez, M.1
Del Mar Viloria, M.2
Andrade, R.J.3
Salmeron, J.4
Diago, M.5
Fernandez-Rodriguez, C.M.6
Corpas, R.7
Cruz, M.8
Grande, L.9
Vazquez, L.10
Munoz-De-Rueda, P.11
Lopez-Serrano, P.12
Gila, A.13
Gutierrez, M.L.14
Perez, C.15
Ruiz-Extremera, A.16
Suarez, E.17
Castillo, J.18
-
33
-
-
0036829856
-
Hepatocellular carcinoma and hepatitis C in the United States
-
El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002;36:S74-S83.
-
(2002)
Hepatology
, vol.36
-
-
El-Serag, H.B.1
-
34
-
-
24944439884
-
National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population
-
Yoshizawa H, Tanaka J, Miyakawa Y: National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 2006;49:7-17.
-
(2006)
Intervirology
, vol.49
, pp. 7-17
-
-
Yoshizawa, H.1
Tanaka, J.2
Miyakawa, Y.3
-
35
-
-
0036595049
-
Suppressors of cytokine signalling (SOCS) in the immune system
-
Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002;2:410-416.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 410-416
-
-
Alexander, W.S.1
-
36
-
-
0037621934
-
Expression of hepatitis C virus proteins inhibits interferon-α signaling in the liver of transgenic mice
-
Blindenbacher A, Duong FH, Hunziker L, Stutvoet ST, Wang X, Terracciano L, Moradpour D, Blum HE, Alonzi T, Tripodi M, La Monica N, Heim MH: Expression of hepatitis C virus proteins inhibits interferon-α signaling in the liver of transgenic mice. Gastroenterology 2003;124:1465-1475.
-
(2003)
Gastroenterology
, vol.124
, pp. 1465-1475
-
-
Blindenbacher, A.1
Duong, F.H.2
Hunziker, L.3
Stutvoet, S.T.4
Wang, X.5
Terracciano, L.6
Moradpour, D.7
Blum, H.E.8
Alonzi, T.9
Tripodi, M.10
La Monica, N.11
Heim, M.H.12
-
37
-
-
0037362931
-
IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3
-
Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Haussinger D: IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 2003;17:488-490.
-
(2003)
FASEB J
, vol.17
, pp. 488-490
-
-
Bode, J.G.1
Ludwig, S.2
Ehrhardt, C.3
Albrecht, U.4
Erhardt, A.5
Schaper, F.6
Heinrich, P.C.7
Haussinger, D.8
-
38
-
-
11144342298
-
Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes
-
De Lucas S, Bartolome J, Carreno V: Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J Infect Dis 2005;191:93-99.
-
(2005)
J Infect Dis
, vol.191
, pp. 93-99
-
-
De Lucas, S.1
Bartolome, J.2
Carreno, V.3
|